Torrent Pharmaceuticals
Search results
A fully integrated pharma company, Aurobindo Pharma features among the top 2 companies in India in terms of consolidated revenues. Aurobindo exports to over 150 countries across the globe with more than 90% of its revenues derived from international operations.
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients.
Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company...
1 day ago · Aurobindo Pharma on Thursday announced that its board has approved the buyback of 51.37 lakh shares at a price of Rs 1,460 per share, representing a premium of 6.4% over Tuesday's closing price. July 30 has been fixed as the record date for the Rs 750 crore share buyback scheme through the tender offer route. Aurobindo's share buyback represents 0.88% of the total number of equity shares in the paid-up equity share capital of the company.
1 day ago · Aurobindo Pharma Ltd. share price moved down by -2.53% from its previous close of Rs 1,371.05. Aurobindo Pharma Ltd. stock last traded price is 1,336.40
Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
Get the latest Aurobindo Pharma Ltd (AUROPHARMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
1 day ago · NSE. Aurobindo Pharma said that it will buyback up to 51.36 lakh equity shares of face value of ₹1, which amounts to 0.88% of the total equity. The buyback price has been fixed as ₹1,460 per share, which is a premium of 6.6% to Aurobindo Pharma's closing price on Tuesday. This is the company's first ever share buyback.
Jun 25, 2024 · Aurobindo Pharma Ltd is a listed public company incorporated on 26 December, 1986. It is classified as a public limited company and is located in Andhra Pradesh, Telangana. It's authorized share capital is INR 666.40 cr and the total paid-up capital is INR 58.59 cr.
